Moderator: Elisabeth Opie

Elisabeth Opie opened a boutique law firm focusing on international technology in Munich, Germany, in 2014. With over 20 years’ international experience in innovation ecosystems, she specialises in dealing with technology across various sectors. Practice areas cover international trade law, technology transfer and commercialisation (including structuring and negotiation strategies), competition law and dispute resolution. Standardised technology is a particular focus. Ms Opie is registered with the Rechtsanwaltskammer München and practises German, English and Australian law.

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More

The U.S. IP Trade Surplus

By Chris Borges As debates over trade balances intensify, policymakers should remember where the United States already excels: the creation, sale, and licensing of intellectual property (IP). IP rights such as patents, copyrights, and trademarks convert ideas into protected and transferable economic assets, promoting innovation and economic growth.
Read More